However, genomic studies have revealed the presence of mutations in genes associated with epigenetic modification (ASXL1, DNMT3A, IDH1/2, TET2, EZH2 and MLL) in a significant proportion of AML patients [26]. This evidence concerns the gene IDH1 and acute myeloid leukemia.